ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright
ProKidney Corp. (NASDAQ:PROK) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, ProKidney Corp.
Prokidney Corp. (PROK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 12,341,266 | $29,865,864 | 0.76% | |
| 2. | Millennium Management Israel Englander | 1,956,378 | $4,734,435 | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 344,789 | $834,389 | 0% | |
| 4. | Squarepoint Ops LLC Maxime Fortin (Cio) | 344,576 | $833,874 | 0% | |
| 5. | Renaissance Technologies Jim Simons | 132,000 | $319,440 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.71 | 387,393 | $276,366.17 | 73,842,723 | 2025-04-22 | Filing | |
| $0.75 | 25,000 | $18,690.00 | 73,455,330 | 2025-04-17 | Filing | |
| $0.75 | 100,000 | $74,820.00 | 73,430,330 | 2025-04-16 | Filing | |
| $0.70 | 468,000 | $326,008.80 | 73,330,330 | 2025-04-15 | Filing | |
| $0.73 | 268,105 | $194,590.61 | 72,862,330 | 2025-04-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.37 | 54,333 | $128,769.21 | 0 | 2025-11-13 | Filing | |
| $2.37 | 447,803 | $1,061,293.11 | 0 | 2025-11-13 | Filing | |
| $2.72 | 27,595 | $75,152.22 | 54,333 | 2025-11-12 | Filing | |
| $2.72 | 227,431 | $619,362.84 | 447,803 | 2025-11-12 | Filing | |
| $3.02 | 103,480 | $312,509.60 | 0 | 2025-07-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,648,229 | $3,692,033 | 0% | |
| 2. | 1,503,886 | $3,368,705 | 0.12% | |
| 3. | 1,000,000 | $2,240,000 | 1.57% | |
| 4. | 416,539 | $933,047 | 0% | |
| 5. | 75 | $168 | 0% |
News See All
13 Best Get Rich Fast Stocks to Buy Right Now
In today's fast-paced world, everyone is prioritising investments that have both high and relatively quick returns.
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth
ProKidney Corp (NASDAQ:PROK) is one of the best healthcare penny stocks to buy now.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
ProKidney Corp (PROK) Completes Re-domestication to Delaware amid Kidney Therapy Advancement
ProKidney Corp. (NASDAQ:PROK) is one of the best high-return penny stocks to buy now.
11 Best High Return Penny Stocks to Buy Now
US equity markets are back at all-time highs amid a muted response to new U.S. tariffs and the trade war. The Nasdaq Composite Index, performing relatively well among major U.S.
10 Hot Penny Stocks to Invest in Now
CNBC reported that consumer prices rose 2.7% year-over-year in June, suggesting that President Trump's tariffs are starting to be felt across the economy.
Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
In this article, we discuss Chamath Palihapitiya and the 12 stocks he pumped in the last 10 years.
ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the ProKidney Corporate Update Conference Call. At this time, all lines are in a listen-only mode.
Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years
Chamath Palihapitiya is the founder of Social Capital, a venture capital firm that he started in 2011.